The role of body composition in neurological and hematologic toxicity in a retrospective analysis of 120 breast cancer patients undergoing neoadjuvant chemotherapy: the COMBOTOX study
A routine assessment of BoCo, in addition to evaluation of anthropometric measures and BMI, could allow to personalize chemotherapy doses, in order to reduce chemotherapy-related toxicities.
Authors
- Lucia Ionta
- Gianluca Franceschini (ORCID: https://orcid.org/0000-0002-2950-3395)
- Stefano Magno (ORCID: https://orcid.org/0000-0002-3721-9693)
- Ida Paris (ORCID: https://orcid.org/0000-0002-7445-3366)
- Alba Di Leone (ORCID: https://orcid.org/0000-0002-8219-5336)
- Lorenzo Scardina (ORCID: https://orcid.org/0000-0002-5828-2851)
- Alessandra Fabi (ORCID: https://orcid.org/0000-0002-0758-8033)
- Pia Clara Pafundi (ORCID: https://orcid.org/0000-0002-0310-3529)
- Cristina Rossi (ORCID: https://orcid.org/0000-0002-9041-2222)
- Claudia Maggiore (ORCID: https://orcid.org/0000-0002-0138-0979)
- Alejandro Martín Sánchez (ORCID: https://orcid.org/0000-0002-4840-507X)
- Annalisa Di Micco
- Alessio Filippone (ORCID: https://orcid.org/0000-0002-3978-846X)
- Antonio De Franco
- Riccardo Masetti (ORCID: https://orcid.org/0000-0002-7520-9111)
- Miriam Rossi
- Luana Forcina
Institutions
- Agostino Gemelli University Polyclinic (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Publication Details
- Journal
- Breast Cancer Research and Treatment
- Published
- 2024-12-04
- DOI
- https://doi.org/10.1007/s10549-024-07553-x
- Citations
- 2
- Primary Topic
- Cancer-related cognitive impairment studies
- Type
- article
- Field-Weighted Citation Impact
- 0.84